Skip to main content

Table 4 Correlation between scale scores and PCS/MCS scale scores.

From: The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability, and scaling assumptions

  PCS MCS
  PF RP BP GH EV SF RE MH PF RP BP GH EV SF RE MH
UK norms [14] 0.79 0.75 0.78 0.64 0.38 0.51 0.11 0.13 0.05 0.26 0.20 0.42 0.73 0.65 0.78 0.89
Cancer Diagnosis                 
all survivors 0.85 0.82 0.73 0.60 0.40 0.62 0.27 0.13 0.13 0.27 0.32 0.53 0.76 0.59 0.73 0.91
leukaemia 0.83 0.81 0.69 0.55 0.33 0.63 0.28 0.13 0.14 0.24 0.36 0.59 0.80 0.57 0.68 0.90
Hodgkin's disease 0.83 0.81 0.72 0.55 0.34 0.61 0.20 0.16 0.09 0.27 0.37 0.55 0.78 0.60 0.77 0.89
non-Hodgkin's 0.85 0.77 0.78 0.70 0.40 0.54 0.25 0.13 0.13 0.29 0.25 0.40 0.78 0.65 0.79 0.92
CNS 0.88 0.82 0.67 0.66 0.47 0.67 0.32 0.11 0.10 0.28 0.37 0.48 0.71 0.54 0.70 0.91
neuroblastoma 0.81 0.80 0.71 0.50 0.32 0.55 0.20 0.07 0.04 0.31 0.45 0.62 0.78 0.67 0.75 0.88
retinoblastoma 0.83 0.83 0.75 0.54 0.31 0.50 0.28 0.05 0.16 0.21 0.26 0.55 0.80 0.64 0.75 0.92
Wilms' tumour 0.85 0.81 0.77 0.67 0.42 0.58 0.24 0.18 0.15 0.30 0.30 0.40 0.75 0.66 0.78 0.90
bone tumour 0.82 0.84 0.85 0.54 0.39 0.60 0.25 0.11 0.23 0.22 0.24 0.54 0.77 0.61 0.77 0.92
soft tissue sarcoma 0.85 0.80 0.78 0.67 0.44 0.52 0.19 0.14 0.11 0.27 0.28 0.44 0.70 0.68 0.81 0.90
other 0.83 0.77 0.80 0.61 0.45 0.60 0.25 0.16 0.17 0.34 0.24 0.52 0.73 0.61 0.78 0.90
Sex                 
Males 0.86 0.81 0.71 0.56 0.35 0.61 0.27 0.11 0.12 0.28 0.35 0.57 0.77 0.59 0.71 0.91
Females 0.85 0.82 0.75 0.63 0.43 0.63 0.27 0.12 0.14 0.27 0.29 0.49 0.75 0.59 0.75 0.91
Age*                 
16–19 0.84 0.82 0.55 0.47 0.28 0.62 0.27 0.10 0.11 0.25 0.49 0.62 0.82 0.58 0.67 0.89
20–29 0.86 0.80 0.71 0.59 0.40 0.59 0.22 0.14 0.10 0.28 0.30 0.52 0.75 0.61 0.76 0.91
30–39 0.85 0.81 0.75 0.57 0.36 0.62 0.27 0.13 0.15 0.28 0.30 0.54 0.78 0.60 0.73 0.90
40–49 0.85 0.84 0.76 0.69 0.44 0.68 0.37 0.14 0.19 0.26 0.31 0.46 0.74 0.56 0.70 0.92
50+ 0.84 0.82 0.82 0.66 0.55 0.65 0.26 0.19 0.23 0.28 0.22 0.50 0.65 0.56 0.75 0.90
Age at diagnosis                 
0–3 0.85 0.82 0.71 0.59 0.36 0.62 0.31 0.11 0.11 0.28 0.36 0.53 0.79 0.59 0.71 0.91
4–7 0.86 0.82 0.69 0.60 0.41 0.65 0.24 0.13 0.11 0.24 0.35 0.53 0.74 0.57 0.74 0.90
8–11 0.87 0.80 0.75 0.59 0.40 0.58 0.27 0.12 0.13 0.31 0.30 0.53 0.75 0.61 0.74 0.91
12–16 0.84 0.82 0.79 0.59 0.40 0.61 0.24 0.13 0.18 0.26 0.26 0.54 0.76 0.61 0.76 0.91
  1. *Age at questionnaire completion
  2. PF: Physical Functioning; RP: Role-Limitation Physical; BP; Bodily Pain; GH: General Health Perception; EV: Energy/Vitality; SF: Social Functioning;
  3. RE: Role-Limitation Emotional: MH: Mental Health